Page last updated: 2024-10-28

hydroxychloroquine and Dysphonia

hydroxychloroquine has been researched along with Dysphonia in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Dysphonia: Difficulty and/or pain in PHONATION or speaking.

Research Excerpts

ExcerptRelevanceReference
"While dermatomyositis affects thousands of individuals in the United States, laryngeal involvement has only been described in a single case report to date."1.39Dysphonia and dermatomyositis: an unusual manifestation. ( McNeill, E; Mims, JW; Wood, MW; Wright, SC, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wood, MW1
McNeill, E1
Mims, JW1
Wright, SC1

Other Studies

1 other study available for hydroxychloroquine and Dysphonia

ArticleYear
Dysphonia and dermatomyositis: an unusual manifestation.
    The Laryngoscope, 2013, Volume: 123, Issue:2

    Topics: Adult; Antirheumatic Agents; Biopsy; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combina

2013